Drugs / Ampicillin/Sulbactam
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00356148 Comparator | Oct 2003 → Mar 2010 | breast cancer | Marmara University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ampicillin/Sulbactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00356148 ↗ |
| Route | Intravenous | “The prophylaxis group received 1 g ampicillin-sulbactam intravenously at anesthesia.” PMID 23001082 ↗ Jan 2013 |